Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in Allogene Therapeutics, Inc.
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC previously held 0 shares of ALLO (Allogene Therapeutics, Inc.), worth $0 as of 2025-Q1.
Final Value
$0
Final Shares
0
Total Value Change
-$761,184
Total Shares Change
-170,287
Other major holders of ALLO: BNP PARIBAS FINANCIAL MARKETS, CAPITAL FUND MANAGEMENT S.A., TPG Group Holdings (SBS) Advisors, Inc.
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $1.55 |
0 |
| 2024-Q4 | Increased | 270,559 | +18.3% | $576,291 | 0.0% | $2.10 | 29 |
| 2024-Q3 | Decreased | 228,806 | -14.2% | $640,658 | 0.0% | $2.91 | 0 |
| 2024-Q2 | Increased | 266,784 | +56.7% | $621,608 | 0.0% | $2.33 | 35 |
| 2024-Q1 | Increased | 170,287 | +8.7% | $761,184 | 0.0% | $4.47 | 27 |